Concepts (316)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atrial Fibrillation | 28 | 2026 | 122 | 4.550 |
Why?
|
| Republic of Korea | 88 | 2026 | 141 | 3.820 |
Why?
|
| Risk Factors | 100 | 2026 | 3994 | 2.630 |
Why?
|
| Incidence | 66 | 2026 | 1078 | 2.450 |
Why?
|
| Cohort Studies | 49 | 2026 | 1759 | 1.690 |
Why?
|
| Stroke | 14 | 2023 | 340 | 1.650 |
Why?
|
| Bronchiectasis | 8 | 2025 | 13 | 1.630 |
Why?
|
| Tuberculosis | 9 | 2024 | 78 | 1.630 |
Why?
|
| Aged | 80 | 2026 | 8214 | 1.540 |
Why?
|
| Drosophila Proteins | 4 | 2024 | 188 | 1.520 |
Why?
|
| Arthritis, Rheumatoid | 7 | 2025 | 58 | 1.480 |
Why?
|
| Middle Aged | 98 | 2026 | 12222 | 1.470 |
Why?
|
| Proportional Hazards Models | 29 | 2026 | 518 | 1.340 |
Why?
|
| Drosophila melanogaster | 4 | 2024 | 193 | 1.260 |
Why?
|
| Hypertension | 10 | 2025 | 835 | 1.250 |
Why?
|
| Female | 108 | 2026 | 24698 | 1.210 |
Why?
|
| Male | 105 | 2026 | 23409 | 1.210 |
Why?
|
| Adult | 84 | 2026 | 13872 | 1.200 |
Why?
|
| Humans | 139 | 2026 | 43102 | 1.160 |
Why?
|
| Kidney Failure, Chronic | 4 | 2025 | 242 | 1.130 |
Why?
|
| Mushroom Bodies | 2 | 2020 | 3 | 1.040 |
Why?
|
| Diabetes Mellitus | 5 | 2024 | 539 | 1.010 |
Why?
|
| Databases, Factual | 18 | 2025 | 341 | 0.970 |
Why?
|
| Nutrition Surveys | 13 | 2020 | 263 | 0.960 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2023 | 193 | 0.940 |
Why?
|
| Cardiomyopathy, Hypertrophic | 5 | 2023 | 25 | 0.880 |
Why?
|
| Dopamine | 2 | 2024 | 275 | 0.880 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 5 | 2025 | 167 | 0.870 |
Why?
|
| Keratosis, Actinic | 2 | 2021 | 4 | 0.860 |
Why?
|
| Ethanol | 2 | 2024 | 224 | 0.850 |
Why?
|
| Receptors, Dopamine | 2 | 2024 | 30 | 0.840 |
Why?
|
| Myocardial Infarction | 8 | 2023 | 247 | 0.820 |
Why?
|
| Dementia, Vascular | 5 | 2023 | 35 | 0.790 |
Why?
|
| Psoriasis | 5 | 2021 | 19 | 0.790 |
Why?
|
| Suicide | 4 | 2025 | 140 | 0.780 |
Why?
|
| Dementia | 5 | 2023 | 160 | 0.780 |
Why?
|
| Acetylcholine | 1 | 2022 | 77 | 0.760 |
Why?
|
| Synaptic Transmission | 1 | 2022 | 149 | 0.720 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2025 | 760 | 0.690 |
Why?
|
| Tuberculosis, Pulmonary | 3 | 2026 | 22 | 0.670 |
Why?
|
| Smoking | 12 | 2025 | 1024 | 0.670 |
Why?
|
| Lung Neoplasms | 5 | 2023 | 495 | 0.670 |
Why?
|
| Neurons | 3 | 2020 | 1263 | 0.660 |
Why?
|
| Receptors, Biogenic Amine | 1 | 2020 | 5 | 0.650 |
Why?
|
| Association Learning | 1 | 2020 | 35 | 0.630 |
Why?
|
| Smell | 1 | 2020 | 40 | 0.630 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 3 | 2025 | 15 | 0.630 |
Why?
|
| Blood Glucose | 7 | 2025 | 389 | 0.620 |
Why?
|
| Retrospective Studies | 22 | 2025 | 2544 | 0.620 |
Why?
|
| Case-Control Studies | 13 | 2026 | 1285 | 0.600 |
Why?
|
| Sleep | 2 | 2017 | 185 | 0.550 |
Why?
|
| Prevalence | 19 | 2024 | 1612 | 0.530 |
Why?
|
| Population Surveillance | 6 | 2021 | 246 | 0.530 |
Why?
|
| Anticoagulants | 5 | 2023 | 122 | 0.520 |
Why?
|
| Esophageal Neoplasms | 4 | 2020 | 140 | 0.520 |
Why?
|
| Peptic Ulcer | 1 | 2016 | 15 | 0.510 |
Why?
|
| Parkinson Disease | 3 | 2024 | 210 | 0.510 |
Why?
|
| Thinness | 4 | 2025 | 32 | 0.490 |
Why?
|
| Anemia | 4 | 2021 | 55 | 0.490 |
Why?
|
| Laryngeal Neoplasms | 3 | 2021 | 13 | 0.490 |
Why?
|
| Diabetic Retinopathy | 4 | 2018 | 78 | 0.480 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2022 | 77 | 0.470 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2021 | 57 | 0.470 |
Why?
|
| Risk Assessment | 11 | 2025 | 863 | 0.460 |
Why?
|
| Hemoglobins | 3 | 2021 | 113 | 0.460 |
Why?
|
| Antirheumatic Agents | 2 | 2025 | 37 | 0.460 |
Why?
|
| Alzheimer Disease | 5 | 2023 | 1001 | 0.460 |
Why?
|
| Aged, 80 and over | 18 | 2025 | 2853 | 0.450 |
Why?
|
| Neoplasms | 3 | 2025 | 1377 | 0.450 |
Why?
|
| Health Surveys | 4 | 2020 | 405 | 0.440 |
Why?
|
| Prediabetic State | 3 | 2022 | 69 | 0.440 |
Why?
|
| Behavior, Animal | 3 | 2024 | 373 | 0.440 |
Why?
|
| Oviposition | 1 | 2014 | 14 | 0.430 |
Why?
|
| Lung Diseases, Interstitial | 2 | 2025 | 13 | 0.430 |
Why?
|
| Alcohol Drinking | 10 | 2026 | 609 | 0.430 |
Why?
|
| Heart Failure | 4 | 2022 | 302 | 0.430 |
Why?
|
| Obesity | 10 | 2023 | 1151 | 0.420 |
Why?
|
| Behcet Syndrome | 2 | 2025 | 3 | 0.420 |
Why?
|
| Cardiovascular Diseases | 4 | 2022 | 749 | 0.420 |
Why?
|
| Signal Transduction | 3 | 2024 | 2157 | 0.420 |
Why?
|
| Young Adult | 22 | 2025 | 5080 | 0.410 |
Why?
|
| Dermatitis, Atopic | 2 | 2024 | 10 | 0.410 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2025 | 20 | 0.410 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 93 | 0.410 |
Why?
|
| Lung Diseases | 2 | 2025 | 63 | 0.400 |
Why?
|
| Follow-Up Studies | 13 | 2024 | 1067 | 0.400 |
Why?
|
| Comorbidity | 8 | 2025 | 737 | 0.400 |
Why?
|
| Cholesterol | 3 | 2025 | 232 | 0.400 |
Why?
|
| Appetitive Behavior | 1 | 2013 | 16 | 0.390 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2013 | 23 | 0.390 |
Why?
|
| Blood Pressure | 4 | 2025 | 666 | 0.390 |
Why?
|
| Depression | 4 | 2025 | 863 | 0.380 |
Why?
|
| Stomach Neoplasms | 3 | 2020 | 241 | 0.370 |
Why?
|
| Tachycardia, Ventricular | 2 | 2023 | 15 | 0.370 |
Why?
|
| Conditioning, Classical | 1 | 2013 | 67 | 0.370 |
Why?
|
| gamma-Glutamyltransferase | 3 | 2023 | 9 | 0.350 |
Why?
|
| Ventricular Premature Complexes | 2 | 2021 | 10 | 0.350 |
Why?
|
| Albuminuria | 3 | 2017 | 78 | 0.340 |
Why?
|
| Longitudinal Studies | 9 | 2026 | 1063 | 0.340 |
Why?
|
| Disease Susceptibility | 5 | 2021 | 101 | 0.330 |
Why?
|
| Colorectal Neoplasms | 3 | 2023 | 512 | 0.320 |
Why?
|
| Aging | 3 | 2022 | 783 | 0.320 |
Why?
|
| National Health Programs | 5 | 2021 | 20 | 0.320 |
Why?
|
| Brain Infarction | 2 | 2020 | 22 | 0.310 |
Why?
|
| Body Mass Index | 8 | 2023 | 925 | 0.310 |
Why?
|
| Asthma | 2 | 2024 | 416 | 0.310 |
Why?
|
| Sexual Behavior, Animal | 1 | 2010 | 64 | 0.310 |
Why?
|
| Body Height | 2 | 2021 | 53 | 0.300 |
Why?
|
| Cause of Death | 5 | 2022 | 186 | 0.290 |
Why?
|
| Life Style | 2 | 2021 | 334 | 0.280 |
Why?
|
| Brain Ischemia | 2 | 2022 | 189 | 0.280 |
Why?
|
| Hearing Loss | 2 | 2020 | 16 | 0.280 |
Why?
|
| Drosophila | 2 | 2022 | 152 | 0.270 |
Why?
|
| Prognosis | 8 | 2023 | 861 | 0.270 |
Why?
|
| Cholesterol, HDL | 2 | 2025 | 99 | 0.270 |
Why?
|
| Fatty Liver | 2 | 2026 | 77 | 0.270 |
Why?
|
| Healthcare Disparities | 2 | 2025 | 590 | 0.260 |
Why?
|
| Animals | 7 | 2024 | 16992 | 0.260 |
Why?
|
| Income | 2 | 2025 | 160 | 0.240 |
Why?
|
| Postmenopause | 4 | 2026 | 141 | 0.240 |
Why?
|
| Diabetic Foot | 1 | 2025 | 6 | 0.240 |
Why?
|
| Korea | 4 | 2019 | 37 | 0.240 |
Why?
|
| Menopause | 1 | 2026 | 64 | 0.240 |
Why?
|
| Ventricular Fibrillation | 2 | 2024 | 10 | 0.230 |
Why?
|
| Pneumonia | 1 | 2025 | 61 | 0.220 |
Why?
|
| Fibrinolytic Agents | 2 | 2022 | 24 | 0.220 |
Why?
|
| Hyperglycemia | 1 | 2025 | 61 | 0.220 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2021 | 31 | 0.210 |
Why?
|
| Uterine Neoplasms | 1 | 2025 | 53 | 0.210 |
Why?
|
| Smoking Cessation | 2 | 2022 | 590 | 0.210 |
Why?
|
| Waist Circumference | 3 | 2021 | 90 | 0.210 |
Why?
|
| Arteritis | 1 | 2024 | 1 | 0.210 |
Why?
|
| Optic Neuropathy, Ischemic | 1 | 2024 | 2 | 0.210 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2024 | 59 | 0.210 |
Why?
|
| Leiomyoma | 1 | 2025 | 42 | 0.210 |
Why?
|
| Central Nervous System Depressants | 1 | 2024 | 42 | 0.210 |
Why?
|
| Multivariate Analysis | 7 | 2021 | 638 | 0.210 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2024 | 46 | 0.210 |
Why?
|
| Scleroderma, Systemic | 1 | 2023 | 12 | 0.210 |
Why?
|
| Insulin Resistance | 2 | 2016 | 201 | 0.210 |
Why?
|
| Spinal Cord Injuries | 1 | 2024 | 69 | 0.210 |
Why?
|
| Heart Arrest | 1 | 2024 | 52 | 0.200 |
Why?
|
| Hip Fractures | 1 | 2023 | 29 | 0.200 |
Why?
|
| Locomotion | 1 | 2024 | 105 | 0.200 |
Why?
|
| Death, Sudden, Cardiac | 4 | 2024 | 31 | 0.200 |
Why?
|
| Registries | 3 | 2021 | 437 | 0.200 |
Why?
|
| Wet Macular Degeneration | 1 | 2023 | 3 | 0.200 |
Why?
|
| Fractures, Bone | 1 | 2023 | 63 | 0.200 |
Why?
|
| Coronary Artery Disease | 2 | 2025 | 163 | 0.200 |
Why?
|
| Administration, Oral | 5 | 2023 | 260 | 0.200 |
Why?
|
| Treatment Outcome | 6 | 2024 | 1604 | 0.190 |
Why?
|
| Causality | 1 | 2022 | 45 | 0.190 |
Why?
|
| Social Behavior | 1 | 2024 | 161 | 0.190 |
Why?
|
| Pancreatitis | 1 | 2022 | 21 | 0.190 |
Why?
|
| Social Environment | 1 | 2024 | 218 | 0.190 |
Why?
|
| Pancreatic Neoplasms | 1 | 2025 | 218 | 0.190 |
Why?
|
| Myocardial Ischemia | 1 | 2023 | 83 | 0.190 |
Why?
|
| Overweight | 3 | 2022 | 249 | 0.190 |
Why?
|
| Weight Gain | 2 | 2020 | 139 | 0.190 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 147 | 0.180 |
Why?
|
| Nasal Obstruction | 1 | 2021 | 2 | 0.180 |
Why?
|
| Nasal Septum | 1 | 2021 | 4 | 0.180 |
Why?
|
| Lung | 1 | 2025 | 492 | 0.180 |
Why?
|
| Migraine Disorders | 1 | 2021 | 9 | 0.180 |
Why?
|
| Upper Gastrointestinal Tract | 1 | 2021 | 4 | 0.180 |
Why?
|
| Uvula | 1 | 2021 | 1 | 0.180 |
Why?
|
| Palate | 1 | 2021 | 3 | 0.180 |
Why?
|
| Toothbrushing | 1 | 2021 | 11 | 0.180 |
Why?
|
| Proton Pump Inhibitors | 1 | 2021 | 16 | 0.180 |
Why?
|
| Motor Activity | 1 | 2024 | 437 | 0.170 |
Why?
|
| Pharynx | 1 | 2021 | 16 | 0.170 |
Why?
|
| Hospitalization | 4 | 2025 | 485 | 0.170 |
Why?
|
| Colonic Neoplasms | 1 | 2023 | 223 | 0.170 |
Why?
|
| Taiwan | 3 | 2025 | 23 | 0.170 |
Why?
|
| Diabetes Complications | 1 | 2021 | 102 | 0.170 |
Why?
|
| Appendectomy | 1 | 2020 | 17 | 0.170 |
Why?
|
| Body Weight | 2 | 2021 | 429 | 0.160 |
Why?
|
| Periodontitis | 1 | 2021 | 62 | 0.160 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 26 | 0.160 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 287 | 0.160 |
Why?
|
| Vitiligo | 1 | 2020 | 3 | 0.160 |
Why?
|
| Vision, Low | 1 | 2020 | 13 | 0.160 |
Why?
|
| Octopamine | 1 | 2020 | 9 | 0.160 |
Why?
|
| Chromosome Aberrations | 1 | 2020 | 61 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 81 | 0.160 |
Why?
|
| Mouth Neoplasms | 1 | 2020 | 60 | 0.160 |
Why?
|
| Animals, Genetically Modified | 1 | 2020 | 100 | 0.160 |
Why?
|
| Mycobacterium Infections | 1 | 2019 | 16 | 0.160 |
Why?
|
| Hyperuricemia | 1 | 2019 | 14 | 0.160 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 10 | 0.150 |
Why?
|
| Sex Factors | 5 | 2025 | 1028 | 0.150 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2020 | 83 | 0.150 |
Why?
|
| Early Detection of Cancer | 2 | 2023 | 449 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2021 | 258 | 0.150 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 140 | 0.150 |
Why?
|
| Survivors | 3 | 2026 | 152 | 0.140 |
Why?
|
| Thiazoles | 1 | 2019 | 76 | 0.140 |
Why?
|
| Cognition | 1 | 2022 | 473 | 0.140 |
Why?
|
| Postoperative Complications | 1 | 2020 | 263 | 0.140 |
Why?
|
| Infant | 4 | 2024 | 1175 | 0.140 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 50 | 0.140 |
Why?
|
| Pyridines | 1 | 2019 | 139 | 0.140 |
Why?
|
| Vitamin K | 1 | 2017 | 9 | 0.140 |
Why?
|
| Fibrosis | 3 | 2023 | 169 | 0.140 |
Why?
|
| Dysphonia | 1 | 2017 | 5 | 0.130 |
Why?
|
| Thromboembolism | 1 | 2017 | 20 | 0.130 |
Why?
|
| Proteinuria | 1 | 2017 | 56 | 0.130 |
Why?
|
| Age Factors | 4 | 2025 | 1154 | 0.130 |
Why?
|
| Logistic Models | 5 | 2019 | 1009 | 0.130 |
Why?
|
| Hemorrhage | 3 | 2023 | 55 | 0.130 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 40 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 89 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2017 | 48 | 0.130 |
Why?
|
| Liver Cirrhosis | 1 | 2017 | 67 | 0.130 |
Why?
|
| Alcoholism | 1 | 2020 | 305 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 178 | 0.120 |
Why?
|
| Olfaction Disorders | 1 | 2016 | 12 | 0.120 |
Why?
|
| Risk | 3 | 2021 | 287 | 0.120 |
Why?
|
| Exercise | 4 | 2023 | 692 | 0.120 |
Why?
|
| Drug Therapy, Combination | 3 | 2022 | 234 | 0.120 |
Why?
|
| Urinary Incontinence | 1 | 2015 | 15 | 0.120 |
Why?
|
| Laryngitis | 1 | 2015 | 2 | 0.120 |
Why?
|
| Blepharoptosis | 1 | 2015 | 4 | 0.120 |
Why?
|
| Tinnitus | 1 | 2015 | 4 | 0.120 |
Why?
|
| Health | 1 | 2015 | 30 | 0.110 |
Why?
|
| Odds Ratio | 4 | 2019 | 587 | 0.110 |
Why?
|
| Oviducts | 1 | 2014 | 13 | 0.110 |
Why?
|
| Cataract | 1 | 2015 | 47 | 0.110 |
Why?
|
| Particulate Matter | 1 | 2015 | 83 | 0.110 |
Why?
|
| Gastritis, Atrophic | 1 | 2014 | 13 | 0.110 |
Why?
|
| Infertility, Female | 1 | 2014 | 24 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 74 | 0.100 |
Why?
|
| Osteoporosis | 1 | 2014 | 45 | 0.100 |
Why?
|
| Severity of Illness Index | 3 | 2024 | 719 | 0.100 |
Why?
|
| Anxiety | 1 | 2021 | 874 | 0.100 |
Why?
|
| Influenza, Human | 1 | 2015 | 92 | 0.100 |
Why?
|
| Cross-Sectional Studies | 6 | 2018 | 3156 | 0.100 |
Why?
|
| Vitamin D | 1 | 2014 | 196 | 0.100 |
Why?
|
| Warfarin | 2 | 2023 | 67 | 0.090 |
Why?
|
| Premenopause | 2 | 2026 | 110 | 0.090 |
Why?
|
| Time Factors | 2 | 2025 | 1857 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 934 | 0.080 |
Why?
|
| Quality of Life | 1 | 2015 | 616 | 0.080 |
Why?
|
| Sex Attractants | 1 | 2010 | 4 | 0.080 |
Why?
|
| Genes, Insect | 1 | 2010 | 27 | 0.080 |
Why?
|
| Vibration | 1 | 2010 | 23 | 0.080 |
Why?
|
| Touch | 1 | 2010 | 19 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2024 | 972 | 0.080 |
Why?
|
| Child | 3 | 2024 | 3443 | 0.080 |
Why?
|
| Survival Rate | 2 | 2021 | 355 | 0.080 |
Why?
|
| Vocalization, Animal | 1 | 2010 | 55 | 0.070 |
Why?
|
| Adolescent | 4 | 2024 | 6081 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2018 | 1092 | 0.070 |
Why?
|
| Creatinine | 2 | 2019 | 102 | 0.070 |
Why?
|
| Breast Neoplasms | 1 | 2019 | 1723 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2024 | 1546 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2025 | 1600 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 386 | 0.070 |
Why?
|
| Spirometry | 1 | 2025 | 40 | 0.060 |
Why?
|
| Respiratory Function Tests | 1 | 2025 | 61 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2025 | 73 | 0.060 |
Why?
|
| Forced Expiratory Volume | 1 | 2025 | 75 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2010 | 735 | 0.060 |
Why?
|
| Factor Analysis, Statistical | 2 | 2015 | 162 | 0.060 |
Why?
|
| Mutation | 1 | 2010 | 1177 | 0.050 |
Why?
|
| Triglycerides | 1 | 2025 | 147 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2024 | 64 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 1234 | 0.050 |
Why?
|
| Rifampin | 1 | 2023 | 8 | 0.050 |
Why?
|
| Antitubercular Agents | 1 | 2023 | 35 | 0.050 |
Why?
|
| Coronary Vessels | 1 | 2023 | 92 | 0.050 |
Why?
|
| Acute Disease | 1 | 2022 | 155 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 59 | 0.050 |
Why?
|
| Heart Function Tests | 1 | 2021 | 12 | 0.040 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 1 | 0.040 |
Why?
|
| Oral Surgical Procedures | 1 | 2021 | 4 | 0.040 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2021 | 2 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2021 | 17 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2021 | 19 | 0.040 |
Why?
|
| Estrogens | 1 | 2022 | 203 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2021 | 116 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 28 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2021 | 185 | 0.040 |
Why?
|
| Gastroscopy | 1 | 2019 | 9 | 0.040 |
Why?
|
| Visual Acuity | 1 | 2020 | 111 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2020 | 132 | 0.040 |
Why?
|
| Chest Pain | 1 | 2020 | 49 | 0.040 |
Why?
|
| Cerebral Infarction | 1 | 2018 | 19 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2019 | 153 | 0.040 |
Why?
|
| Blood Coagulation | 1 | 2019 | 29 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2019 | 38 | 0.040 |
Why?
|
| Patient Participation | 1 | 2019 | 94 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2018 | 30 | 0.030 |
Why?
|
| Weight Loss | 1 | 2019 | 137 | 0.030 |
Why?
|
| Liver | 1 | 2021 | 511 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2019 | 411 | 0.030 |
Why?
|
| Mortality | 1 | 2018 | 175 | 0.030 |
Why?
|
| Fasting | 1 | 2017 | 56 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 734 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 440 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 368 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 490 | 0.030 |
Why?
|
| Reference Values | 1 | 2016 | 211 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 1772 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2015 | 162 | 0.030 |
Why?
|
| Age Distribution | 1 | 2015 | 249 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2014 | 29 | 0.030 |
Why?
|
| Seasons | 1 | 2015 | 139 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1596 | 0.030 |
Why?
|
| Particle Size | 1 | 2015 | 272 | 0.030 |
Why?
|
| Influenza Vaccines | 1 | 2015 | 58 | 0.030 |
Why?
|
| Insulin | 1 | 2016 | 258 | 0.030 |
Why?
|
| Eating | 1 | 2015 | 167 | 0.030 |
Why?
|
| Data Collection | 1 | 2014 | 210 | 0.030 |
Why?
|
| Lipids | 1 | 2015 | 256 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2015 | 549 | 0.020 |
Why?
|